Performances in N.Y.C. Advertisement Supported by A week before opening night, tensions spilled over offstage, with the show’s producing team temporarily prohibiting Stephen Adly Guirgis from entering ...

Structure Therapeutics Inc.’s shares rose after more data on the company’s experimental weight-loss pill showed it’s shaping up to rival new oral treatments from Novo Nordisk A/S and Eli Lilly & Co.

Structure Therapeutics’ oral obesity drug elicited a placebo-adjusted weight loss of 16.3% at 44 weeks in a Phase 2 trial. The biotech is planning to launch a late-stage program for the drug later ...

The recipients of the 2025 Steinberg Playwright Awards (the “Mimi” Awards), presented by the Harold and Mimi Steinberg Charitable Trust, are Christopher Chen and Zora Howard. The $100,000 award is ...

Most solid materials we rely on, from steel, to plastics and ceramics, are designed to have specific properties. Whether a material is soft and flexible, or stiff and tough depends on how molecules ...

When Tracy Letts penned his play “Bug” 30 years ago, it seemed to come at a specific moment when conspiracy theories had become more integrated into mainstream society. Letts, who would go on to win a ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

After a few false starts trying to dive into the play, I found a deeply satisfying solution: I retyped the play in its entirety: not just reading it passively and taking notes, but actually writing ...

Strip the types and hotwire the HTML—and triple check your package security while you are at it. JavaScript in 2026 is just getting started. I am loath to inform you that the first month of 2026 has ...

Playwright Justin Tanner, author of “Pot Mom,” “Little Theatre” and “Voice Lessons,” is one of the signal voices of L.A.’s wild and free intimate theater scene. He has not only written what might be ...

In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to secure a license from Structure Therapeutics. The agreement grants Roche and ...